Infections During Pregnancy

Key Points

• Maternal infections can occur at any gestational stage, but early-pregnancy infections often cause greater fetal harm during organogenesis.
• Vertical transmission may occur transplacentally (for example TORCH pathways) or during labor/delivery (for example GBS exposure).
• Core nursing responsibilities include prevention education, screening coordination, symptom assessment, treatment support, and multidisciplinary follow-up.
• Pregnancy pathways require organism-specific plans for hepatitis, HIV, TORCH organisms, herpes, varicella, and GBS.
• Maternal and neonatal outcomes improve when screening and prophylaxis are timed correctly.

Pathophysiology

Infection during pregnancy can disrupt placental function, fetal development, and maternal physiology simultaneously. Transplacental infections can injure developing organs, while intrapartum exposure can trigger severe early neonatal infection.

Risk and severity depend on pathogen type, timing of exposure, maternal immune status, and treatment timing. Early detection allows targeted therapy, prophylaxis, and delivery planning to reduce fetal and neonatal complications.

Classification

• Transplacental pathway: TORCH-pattern infections (toxoplasmosis, syphilis, rubella, cytomegalovirus, herpes) and selected viral infections.
• Intrapartum exposure pathway: Organisms transmitted during labor and birth, especially group B streptococcus.
• Maternal chronic-viral pathway: Hepatitis B/C and HIV requiring prenatal screening plus neonatal prevention planning.
• Complication domain: Pregnancy loss, preterm birth, fetal growth restriction, congenital malformations, and neonatal sepsis.

Nursing Assessment

NCLEX Focus

Prioritize gestational timing, transmission route, and organism-specific neonatal risk when triaging maternal infection findings.

• Assess infection symptoms and exposure history (sexual, foodborne, respiratory, body-fluid, occupational, and household exposures).
• Confirm first-prenatal-visit screening completion for hepatitis B/C, HIV, and syphilis; verify repeat testing plans when risk remains high.
• Assess fetal-movement trends, growth findings, and ultrasound abnormalities that may indicate fetal infection impact.
• Assess high-risk contexts such as HIV coinfection, immunosuppression, childcare exposure settings, or prolonged rupture of membranes.
• Assess GBS pathway risks near delivery, including preterm labor, prolonged membrane rupture, prior affected newborn, and chorioamnionitis.

Nursing Interventions

• Provide prevention teaching: hand hygiene, safe food handling, safer sex practices, vaccination planning, and prenatal-care adherence.
• Coordinate organism-specific screening and confirmatory testing (for example RPR/VDRL with treponemal confirmation for syphilis, HBsAg and viral-load follow-up for hepatitis B).
• Support treatment plans and monitoring:
• Hepatitis B: newborn vaccine plus HBIG within 12 hours when maternal HBsAg is positive.
• Hepatitis C: postpartum antiviral planning when treatment is deferred in pregnancy.
• Toxoplasmosis: exposure avoidance (cat feces, undercooked meat) and gestational-age-specific therapy planning.
• HSV: suppressive antiviral planning from late pregnancy and cesarean planning if active genital lesions are present at labor.
• GBS: intrapartum IV antibiotic prophylaxis when indicated.
• Coordinate multidisciplinary maternal-fetal and neonatal planning with obstetric, infectious-disease, pediatrics, and lactation teams.
• Provide counseling and psychosocial support for prolonged high-risk infection monitoring.

Timing-Critical Prevention

Delays in screening, prophylaxis, or intrapartum antibiotics can convert manageable maternal infection into preventable congenital or neonatal harm.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
antibiotics	penicillin for GBS and syphilis contexts	Timing and regimen completion are critical to prevent neonatal infection and congenital complications.
antiviral-medications	acyclovir (HSV suppression), HBV antivirals by viral-load plan	Use pathogen-specific timing; some regimens are deferred until postpartum in HCV pathways.
immune-globulins	HBIG for newborns of HBsAg-positive mothers	Must be coordinated with newborn vaccine within the immediate postbirth window.

Clinical Judgment Application

Clinical Scenario

A 37-week pregnant patient has positive GBS culture, intermittent contractions, and history of prolonged membrane rupture in a prior pregnancy.

• Recognize Cues: Near-term GBS positivity with elevated neonatal-sepsis risk profile.
• Analyze Cues: Intrapartum transmission risk is high without timely antibiotic prophylaxis.
• Prioritize Hypotheses: Immediate priority is intrapartum infection prevention and neonatal safety planning.
• Generate Solutions: Initiate intrapartum antibiotic pathway, communicate handoff status, and prepare newborn monitoring plan.
• Take Action: Administer ordered IV antibiotics during labor and maintain maternal-fetal surveillance.
• Evaluate Outcomes: Delivery occurs with prophylaxis completed and newborn is monitored without early-onset sepsis signs.

Related Concepts

• conditions-limited-to-pregnancy - Integrates infection pathways into broader high-risk pregnancy triage.
• hepatitis-b - Details prenatal HBV screening and newborn HBIG-vaccine prophylaxis planning.
• hepatitis-c - Outlines maternal HCV monitoring and postpartum antiviral treatment timing.
• hiv - Defines ART-centered perinatal transmission prevention and feeding counseling.
• sexually-transmitted-infections - Covers syphilis and HSV pregnancy implications and diagnostic workflows.
• vaginal-infections-and-other-conditions - Includes GBS screening and intrapartum prophylaxis workflow.

Self-Check

1. Why does infection timing in pregnancy change fetal-risk severity?
2. Which maternal infections require delivery-timed neonatal prophylaxis planning?
3. Which findings should trigger immediate escalation for congenital-infection risk?